Rewriting the PBM Playbook: Exposing Hidden Costs and Empowering Plan Sponsors

Why It Matters

These concealed cost drivers erode the financial health of employers and public plans, prompting a need for greater transparency and strategic contract management in the pharmacy benefits space.

Key Takeaways

• Big Three PBMs control ~80% of U.S. prescription claims.
• Spread pricing lets PBMs charge sponsors more than pharmacies receive.
• Rebate retention can bias formulary toward higher‑priced, high‑rebate drugs.
• Specialty pharmacy margins amplify profits on high‑cost specialty drugs.
• Opaque MAC lists and repackaged NDCs add hidden costs for sponsors.

Pulse Analysis

The pharmacy‑benefit landscape is increasingly dominated by three megastructures—CVS Caremark, Express Scripts and OptumRx—whose combined revenue eclipses $456 billion. Their market share gives them leverage over drug pricing, formulary design, and network selection, creating a fertile environment for profit mechanisms that remain largely invisible to plan sponsors. Understanding this concentration is essential for employers, insurers, and public entities that shoulder the bulk of prescription spend.

At the core of PBM profitability are spread pricing, rebate retention, and specialty pharmacy margins. Spread pricing captures the difference between what a PBM pays a pharmacy and what it bills the sponsor, while retained manufacturer rebates often steer formulary placement toward higher‑priced drugs that generate larger kickbacks. Specialty pharmacies, frequently owned or tightly controlled by PBMs, add mark‑ups on high‑cost therapies, magnifying overall spend. Lesser‑known tactics—such as inflating Average Wholesale Prices through repackaged NDCs, manipulating proprietary MAC lists, and layering administrative or data‑access fees—further obscure true costs and erode sponsor savings.

For sponsors, the path forward lies in demanding granular data, clear pass‑through language, and independent audit rights. Engaging pharmacy‑benefits consultants can surface hidden fees, benchmark pricing, and negotiate contracts that align PBM incentives with sponsor goals. As the industry evolves, pass‑through models that eliminate spread and enforce full rebate pass‑through are gaining traction, promising greater transparency and cost control for plan sponsors seeking to protect their bottom line.